Lifecore Biomedical Azioni (NASDAQ: LFCR)

Lifecore Biomedical

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

LFCR

SPSC

Analisi delle performance di GeneDx, Lifecore Biomedical, UDR e i loro ultimi sviluppi nel mercato per il trading di oggi.

Resources Connection, SPS Commerce e altre 3 azioni da tenere d&#39;occhio

XPEV

Con futures azionari in rialzo, ecco le ultime novità su Nio, Li Auto e XPeng, tra le azioni da tenere d&#39;occhio oggi.

Nio, Li Auto e XPeng e le altre azioni da monitorare oggi

Lifecore Biomedical Inc

Contracts

Press Releases

Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 2025

Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update

Legal

LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Health Care

Lifecore Biomedical to Participate in Upcoming Investor Conferences

Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

LIFECORE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

LIFECORE SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Lifecore Biomedical, Inc. and Encourages Long-Term Investors to Contact the Firm – LFCR

Applied DNA Sciences, Inc. - Common Stock

Applied DNA Sciences

Atlantic International Corp. - Common Stock

Atlantic International

Bionano Genomics

Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A

Bruker

Codexis

Champions Oncology

Cytek Biosciences

CryoPort

Harvard Bioscience

MindWalk Holdings

Standard BioTools

Mesa Laboratories

Maravai LifeSciences Holdings, Inc. - Class A common stock

Maravai LifeSciences

MaxCyte

Niagen Bioscience

Nautilus Biotechnology, Inc. - Common Stock

Nautilus Biotechnology

Inotiv

OmniAb

Pacific Biosciences of California, Inc. - Common Stock

Pacific Biosciences

Personalis

Quantum-Si Incorporated - Class A Common Stock

Quantum-Si

Quanterix

Rapid Micro Biosystems, Inc. - Class A Common Stock

Rapid Micro Biosystems

Seer

Alpha Teknova

Stephens & Co.

Craig-Hallum

Comments

Lifecore Biomedical

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO